ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally. The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control. Its product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers. The company was founded in 2004 and is headquartered in Oakwood, Ohio. On July 16, 2023, ViewRay, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.
Frequently asked questions
What sector does ViewRay Inc. (VRAYQ) operate in?
ViewRay Inc. belongs to the Healthcare sector and operates in the Medical Devices industry.
What is ViewRay Inc. (VRAYQ) current stock price?
As of the latest data, ViewRay Inc. stock price is $0.00, with a previous close of $0.00.
What is ViewRay Inc. (VRAYQ) current market capitalization?
ViewRay Inc. market cap is approximately 18.34 thousand.
What is ViewRay Inc. (VRAYQ) Earnings Per Share (EPS)?
The trailing EPS is -$6.00.
Does ViewRay Inc. (VRAYQ) pay dividends?
No. ViewRay Inc. does not pay a dividend.
What is ViewRay Inc. (VRAYQ) beta (volatility) score?
ViewRay Inc. has a beta of -22.309, indicating lower volatility than the overall market.